Department of Physical Medicine and Rehabilitation, Cleveland Clinic, Cleveland, OH; Department of Biomedical Engineering, Cleveland Clinic, Cleveland, OH; Concussion Center, Cleveland Clinic, Cleveland, OH.
Concussion Center, Cleveland Clinic, Cleveland, OH.
Arch Phys Med Rehabil. 2021 Jan;102(1):1-8. doi: 10.1016/j.apmr.2020.08.006. Epub 2020 Sep 9.
To determine the efficacy of high-intensity cycling to improve walking capacity in individuals with chronic stroke, identify variables that predict improvement in walking capacity, and quantify the relationship between the 6-minute walk test (6MWT) and cardiopulmonary exercise (CPX) test variables.
Secondary analysis of data from 2 randomized controlled trials.
Research laboratory.
Individuals with chronic stroke (N=43).
Participants were randomized to 1 of the following time-matched interventions, occurring 3 times per week for 8 weeks: (1) forced aerobic exercise and upper extremity repetitive task practice (FE+RTP [n=16]), (2) voluntary aerobic exercise and upper extremity repetitive task practice (VE+RTP [n=14]), or (3) a non-aerobic control group (n=13).
Change in walking capacity as measured by the 6MWT from baseline to the end of treatment (EOT).
Significant increases were observed in distance traveled during the 6MWT at the EOT compared with baseline in the FE+RTP (P<.001) and VE+RTP (P<.001) groups, but not in the control group (P=.21). Among aerobic exercise participants, a multivariate regression analysis revealed that cycling cadence, power output, and baseline 6MWT distance were significant predictors of change in walking capacity.
An 8-week aerobic cycling intervention prescribed at 60% to 80% of heart rate reserve and moderate to high cadence and resistance led to significant improvements in walking capacity in our cohort of individuals with chronic stroke. Individuals with low baseline walking capacity levels may benefit most from aerobic cycling to improve over ground locomotion. Although the 6MWT did not elicit a cardiorespiratory response comparable to the maximal exertion CPX test, the 6MWT can be considered a valid and clinically relevant submaximal test of cardiorespiratory function in individuals with chronic stroke.
确定高强度骑行对改善慢性脑卒中患者步行能力的疗效,确定预测步行能力改善的变量,并量化 6 分钟步行测试(6MWT)和心肺运动(CPX)测试变量之间的关系。
对 2 项随机对照试验数据的二次分析。
研究实验室。
慢性脑卒中患者(N=43)。
参与者随机分为以下 1 组时间匹配的干预措施,每周 3 次,共 8 周:(1)强制有氧运动和上肢重复任务练习(FE+RTP[ n=16]),(2)自愿有氧运动和上肢重复任务练习(VE+RTP[ n=14])或(3)非有氧运动对照组(n=13)。
从基线到治疗结束(EOT)时 6MWT 测量的步行能力变化。
与对照组相比(P=.21),FE+RTP(P<.001)和 VE+RTP(P<.001)组在 EOT 时 6MWT 中行走距离明显增加,而对照组则没有增加。在有氧运动参与者中,多元回归分析显示,踏频、功率输出和基线 6MWT 距离是步行能力变化的显著预测因子。
我们对慢性脑卒中患者进行了 8 周的有氧踏车干预,运动强度设定为心率储备的 60%至 80%,踏频和阻力适中至较高,这使患者的步行能力得到了显著改善。基线步行能力较低的患者可能从有氧踏车运动中获益最大,以改善地面运动。尽管 6MWT 不能引起与最大努力 CPX 测试相当的心肺反应,但 6MWT 可被视为慢性脑卒中患者心肺功能的有效和临床相关亚最大测试。